Suchergebnisse - "Lin, Tara L"

PubPharm (86)

1

Evaluating the impact of delayed study startup on accrual in cancer studies

enthalten in: ResearchSquare.com | 2024

von Ratnayake, I. | Do, A. | Gajewski, D. | +7

2

Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer center

enthalten in: Contemporary clinical trials communications | 2024

von Shi, X. | Mudaranthakam, D. | Wick, J. | +7

3

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

enthalten in: Leukemia | 2024

von Garcia-Manero, G. | Podoltsev, N. | Othus, M. | +23

4

Response to 'blast identification in cerebrospinal fluid specimens from patients with acute myeloid leukemia : laboratory perspectives'

enthalten in: Leukemia & lymphoma | 2024

von Sastow, D. | Tatarian, J. | Salib, C. | +2

5

The approach of HMA plus VEN with or without BMT for all patients with AML

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Male, H. | Lin, T.

6

Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement

enthalten in: Leukemia & lymphoma | 2023

von Sastow, D. | Tatarian, J. | Riazat-Kesh, Y. | +9

7

Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2023

von Croucher, P. | Ridinger, M. | Becker, P. | +4

8

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy : A Phase IB Study in Patients With Newly Diagnosed AML

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Pratz, K. | Cherry, M. | Altman, J. | +15

9

Standardising acute myeloid leukaemia classification systems : a perspective from a panel of international experts

enthalten in: The Lancet. Haematology | 2023

von Shallis, R. | Daver, N. | Altman, J. | +38

10

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype : A phase 2 substudy of the Beat AML Master Trial

enthalten in: Cancer | 2023

von Duong, V. | Ruppert, A. | Mims, A. | +34

1
2
3
4
5
6
7
8
9
Nächster »
[9]